Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day, everyone, and welcome to the InspireMD Third Quarter ...

Solaris Endovascular, Inc. proudly announces its formation to develop solutions for Dialysis Access and Peripheral Artery disease (PAD). Solaris Endovascular develops evidence-based technologies, ...

InspireMD Inc., a Delaware-based medical device company, focuses on the development and commercialization of its proprietary MicroNet™ stent platform technology, which is used in the treatment of ...

Several falls ago, Jean was in Brazil, pursuing her annual fly rod peacock bass adventures in the Amazon. While carrying two ...

A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...

NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced financial and operating results for the third ...

The results in patients with long, complex lesions are better than or equal to those of surgery, but without the ...

Stents are, of course, used in other scenarios to open large arteries. The new stent, with its unique pinched-in-the-middle ...

The global Coronary Stents Market is projected to reach a substantial USD 51.2 billion by 2032, reflecting a steady growth ...